Literature DB >> 27122476

Transcutaneous and Percutaneous Neurostimulation for Headache Disorders.

Matthew S Robbins1,2, Richard B Lipton2.   

Abstract

Noninvasive and minimally invasive extracranial stimulation has now been widely investigated for the treatment of primary headache disorders, particularly migraine. In this review, we describe methodological challenges in studying occipital and supraorbital stimulation devices. We explore the efficacy and safety of implantable occipital nerve stimulation for primary headache disorders, including the 3 randomized, sham-controlled clinical trials for chronic migraine treatment. We also review noninvasive supraorbital transcutaneous stimulation as a preventive therapy for episodic migraine.
© 2016 American Headache Society.

Entities:  

Keywords:  chronic; intractable; migraine; minimally invasive; neuromodulation; neurostimulation; noninvasive; occipital; refractory; supraorbital

Mesh:

Year:  2016        PMID: 27122476     DOI: 10.1111/head.12829

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  4 in total

Review 1.  Complementary and Integrative Medicine for Neurologic Conditions.

Authors:  Rebecca Erwin Wells; Vanessa Baute; Helané Wahbeh
Journal:  Med Clin North Am       Date:  2017-06-23       Impact factor: 5.456

Review 2.  Treatment Update of Chronic Migraine.

Authors:  Soo-Jin Cho; Tae-Jin Song; Min Kyung Chu
Journal:  Curr Pain Headache Rep       Date:  2017-06

3.  Effectiveness of transcutaneous electrical nerve stimulation for the treatment of migraine: a meta-analysis of randomized controlled trials.

Authors:  Huimin Tao; Teng Wang; Xin Dong; Qi Guo; Huan Xu; Qi Wan
Journal:  J Headache Pain       Date:  2018-05-29       Impact factor: 7.277

4.  External Concurrent Occipital and Trigeminal Neurostimulation Relieves Migraine Headache: A Prospective, Randomized, Double-Blind, Sham-Controlled Trial.

Authors:  Oved Daniel; Stewart J Tepper; Lisa Deutsch; Roni Sharon
Journal:  Pain Ther       Date:  2022-06-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.